Lance Armstrong in August 2012. Image courtesy of Shutterstock.
Washington Post sports columnist Sally Jenkins has been Lance Armstrong’s most steadfast supporter. How will she respond to the
latest reports that Armstrong relied on performance-enhancing drugs to win all seven
of his Tour de France titles?
When the US Anti-Doping Agency accused Armstrong in August of ingesting drugs to fuel
his climbs in the mountains of France and sprints toward Paris, Jenkins took to the
pages of the Post.
“First of all,” she wrote, “Lance Armstrong is a good man.” She added: “I do know
that he beat cancer fair and square, that he’s not the mastermind criminal the USADA
makes him out to be, and that the process for stripping him of his titles reeks.”
she mentioned she has written two books with Armstrong. Her
defense is well founded.
What now? How will Jenkins defend Armstrong from the reams of documents the USADA
released this week? The agency backs up its damning dossier with financial records,
laboratory results, and witness testimony. Eleven former teammates testified that
Armstrong employed a variety of ruses to evade blood testing that might have incriminated
him. Among them are veteran cyclists George Hincapie, Tyler Hamilton, and Floyd Landis, who himself was stripped of the 2006 Tour title on doping charges.
When USADA first announced its charges in August, Jenkins attacked the messenger.
She asked, “How does an agency that is supposed to regulate drug testing strip a guy
of seven titles without a single positive drug test?”
The USADA appears to have answered that question. It recounts how Armstrong deliberately
avoided testing through a warning system. On one occasion, according to the USADA,
Armstrong dropped out of a race when a teammate alerted him that drug testers were
at the team’s hotel.
Sally Jenkins is one of the Post’s most brave and incisive columnists. In the case of Lance Armstrong, she has tied
herself to his fortunes, to his veracity, to his worthiness as a champion. If he takes
a fall, will she write about it? Will she take one, too?
Jenkins has yet to respond to questions about whether she would write about Armstrong’s
latest travails. Her readers deserve her take.
What Is Post Columnist Sally Jenkins’s Take on Latest Lance Armstrong Charges?
Jenkins has written two books with Armstrong—but what will happen if he takes a fall is unclear.
Washington Post sports columnist
Sally Jenkins has been Lance Armstrong’s most steadfast supporter. How will she respond to the
latest reports that Armstrong relied on performance-enhancing drugs to win all seven
of his Tour de France titles?
When the US Anti-Doping Agency accused Armstrong in August of ingesting drugs to fuel
his climbs in the mountains of France and sprints toward Paris, Jenkins took to the
pages of the
Post.
“First of all,” she wrote, “Lance Armstrong is a good man.” She added: “I do know
that he beat cancer fair and square, that he’s not the mastermind criminal the USADA
makes him out to be, and that the process for stripping him of his titles reeks.”
Three paragraphs into her August 24
column,
she mentioned she has written two books with Armstrong. Her
defense is well founded.
What now? How will Jenkins defend Armstrong from the reams of documents the USADA
released this week? The agency backs up its damning dossier with financial records,
laboratory results, and witness testimony. Eleven former teammates testified that
Armstrong employed a variety of ruses to evade blood testing that might have incriminated
him. Among them are veteran cyclists
George Hincapie,
Tyler Hamilton, and
Floyd Landis, who himself was stripped of the 2006 Tour title on doping charges.
When USADA first announced its charges in August, Jenkins attacked the messenger.
She asked, “How does an agency that is supposed to regulate drug testing strip a guy
of seven titles without a single positive drug test?”
The USADA appears to have answered that question. It recounts how Armstrong deliberately
avoided testing through a warning system. On one occasion, according to the USADA,
Armstrong dropped out of a race when a teammate alerted him that drug testers were
at the team’s hotel.
Sally Jenkins is one of the
Post’s most brave and incisive columnists. In the case of Lance Armstrong, she has tied
herself to his fortunes, to his veracity, to his worthiness as a champion. If he takes
a fall, will she write about it? Will she take one, too?
Jenkins has yet to respond to questions about whether she would write about Armstrong’s
latest travails. Her readers deserve her take.
Most Popular in News & Politics
What to Expect From the Lady Gaga Concert Tonight at Nats Park
A Facebook Group Is Helping DC Women Dig Up Dirt on Potential Dates
Washington DC’s 500 Most Influential People
This New DC Bookstore Sells Only Queer-Focused Books
More and More Women Are Paying Alimony to Failure-to-Launch Ex-Husbands. And They’re Really, Really Not Happy About It.
Washingtonian Magazine
August 2022: Taco Town
View IssueSubscribe
Follow Us on Social
Follow Us on Social
Related
Guest List: 5 People We’d Love to Hang Out With This August
Why Do We Care So Much About Presidential Pooches?
The Tiny DC Art Space With a 20-Year History
Telling the Stories of 7,700 People Buried at Arlington Cemetery
More from News & Politics
Monkeypox: What Washingtonians Need to Know
Guest List: 5 People We’d Love to Hang Out With This August
This New DC Bookstore Sells Only Queer-Focused Books
STUDY: Commanders Fans Are NFL’s Least Optimistic
What to Expect From the Lady Gaga Concert Tonight at Nats Park
Covid, Inflation, Politics—They’re All Affecting Your Sleep. Here’s How to Snooze More Soundly.
This Secret Service Officer Was on the Scene at the Lightning Strike
Last Night’s Storm Had an Unusual Amount of Lightning